Federal grants to Raft Pharmaceuticals LLC
Raft Pharmaceuticals LLC in San Diego, California received $6.3 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.0 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.3 million
- Awards4
- Awarded in FY 2025$1.0 million
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 4 | $2.7 million |
| FY 2024 | 2 | $1.3 million |
| FY 2025 | 1 | $1.0 million |
Programs that fund Raft Pharmaceuticals LLC
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 1 | $3.0 million |
| Drug Use and Addiction Research Programs | 2 | $2.7 million |
| Aging Research | 1 | $500,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $6.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Targeting lipid rafts for treatment of asthma - project summary patients with severe asthma who display persistent bronchoconstriction and/or reduced lung function despite available bronchodilator, corticosteroid and TH2-TARGETING therapy develop significant morbidity, which severely impacts their q | Allergy and Infectious Diseases Research | March 31, 2023 | $3.0 million |
| Novel biologic to treat chemotherapy-induced neuropathic pain - project summary chemotherapy-induced peripheral neuropathy (CIPN) has a profound negative impact on quality of life of nearly 70% of cancer patients receiving chemotherapy. While systemic administration of opiates, nsaids, and anticonvu | Drug Use and Addiction Research Programs | September 19, 2022 | $2.0 million |
| Targeting TLR4-LIPID rafts to prevent postoperative pain - project summary postoperative pain is a prevalent source of pain requiring appropriate management to reduce its impact upon quality of life. Even with the availability of several analgesics, postoperative pain is often undermedicated because | Drug Use and Addiction Research Programs | September 20, 2023 | $698,036 |
| Aav-aibp therapy for alzheimer's disease - project summary therapy for alzheimer’s disease and related dementias (ad/adrd), slow-progressing neurodegenerative diseases, remains elusive. Therapeutic approaches focusing on beta amyloid (ASS) removal from the brain or on targeting genes for which stron | Aging Research | September 21, 2022 | $500,000 |
Questions people ask
How much federal grant money does Raft Pharmaceuticals LLC get?
$6.3 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Raft Pharmaceuticals LLC the most?
The Department of Health and Human Services, with $6.3 million in 4 awards.
What is Raft Pharmaceuticals LLC's largest federal grant?
$3.0 million under Allergy and Infectious Diseases Research, with its first action in the period on March 31, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Raft Pharmaceuticals LLC?
Its largest are Allergy and Infectious Diseases Research, Drug Use and Addiction Research Programs and Aging Research.
Other grant recipients in San Diego
- San Diego Association of Governments
- Metropolitan Transit System
- General Atomics
- Neighborhood House Association
- San Diego County Regional Airport Authority
- San Diego State University Foundation
- San Diego Unified School District
- Family Health Centers of San Diego Inc
Largest federal grant recipients in California · Federal grants in California